OCTOBER 2024LIFE SCIENCES REVIEW5CXO INSIGHTSEarly Phase Biologics Characterization; a Key Factor for Risks Mitigation in Biologics Product DevelopmentsRafael Sande,Head Operations Characterization, Large Molecules and ATMP Services,Solvias26Holistic Compliance in Healthcare OrganizationsZina Safer,Chief Legal & Sustainability Officer,Uriach17Adopting Blockchain Technologyfor Clinical Trial ManagementTomaz Vaupotic,Senior Director, Head of Clinical & Medical Quality,Alvotech28Establishing a Biotech company in Europe:A mission impossible?Rüdiger Schulze,Vice President and General Manager, DACH,Ultragenyx20Grappling with Unpredictability: The Art and Science of Pandemic PreparednessMarc Lacey,Exec Director - Global Pandemic Head,Seqirus22A Marketer's Guide to Strategically Promoting Oncology InnovationJaime Manzanera Gómez,Brand Director of Oncology,Eisai EMEA24BIOVIIIxDavide Rosiello, CEOHEMOPHILIA COMPANY OF THE YEAR IN EUROPE 202418
< Page 4 | Page 6 >